Central Trust Company’s Axcelis ACLS Stock Holding History

Central Trust Company’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115K	Sell	1,237 -113	-8%	-$10K	﹤0.01%	693
2025 Q4	$108K	Hold	1,350	–	–	﹤0.01%	681
2025 Q3	$132K	Hold	1,350	–	–	﹤0.01%	647
2025 Q2	$94.1K	Buy	1,350 +1,237	+1,095%	+$70.6K	﹤0.01%	682
2025 Q1	$5.61K	Hold	113	–	–	﹤0.01%	1194
2024 Q4	$7.9K	Hold	113	–	–	﹤0.01%	1144
2024 Q3	$11.8K	Hold	113	–	–	﹤0.01%	1041
2024 Q2	$16.1K	Hold	113	–	–	﹤0.01%	980
2024 Q1	$12.6K	Hold	113	–	–	﹤0.01%	1041
2023 Q4	$14.7K	Hold	113	–	–	﹤0.01%	1007
2023 Q3	$18.4K	Hold	113	–	–	﹤0.01%	946
2023 Q2	$20.7K	Hold	113	–	–	﹤0.01%	926
2023 Q1	$15.1K	Buy	+113	New	+$13.3K	﹤0.01%	985

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Central Trust Company's ACLS Position: Q1 2026 in Review

Central Trust Company reduced its Axcelis (ACLS) stake by 8.4% in Q1 2026, selling an estimated $10K and leaving 1,237 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Central Trust Company first reported a position in ACLS in Q1 2023 and has held it in 13 quarters since. The position peaked at $132K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

Central Trust Company held 1,237 shares of Axcelis worth $115K as of Q1 2026.
Central Trust Company sold 113 Axcelis shares in Q1 2026, an estimated $10K.
Axcelis made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #693 holding.
Central Trust Company first reported a position in Axcelis in Q1 2023 and has held it in 13 quarters since.
Central Trust Company's Axcelis position peaked at $132K in Q3 2025.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.